Limits...
Basal cell carcinoma: a single-center experience.

Abbas OL, Borman H - ISRN Dermatol (2012)

Bottom Line: Although there is relatively low attributable mortality, the morbidity and cost of treatment are significant.A large body of information serves as a foundation for oncologic principles, diagnosis methods, surgical excisions, follow-up protocols, and reconstructive methodologies that are currently in use.Surgical ablation remains the mainstay of treatment.

View Article: PubMed Central - PubMed

Affiliation: Department of Plastic, Reconstructive and Aesthetic Surgery, Baskent University Faculty of Medicine, 40000 Ankara, Turkey.

ABSTRACT
Background. Basal cell carcinoma comprises the vast majority of skin cancers. It predominantly affects fair-skinned individuals, and its incidence is rising rapidly. Etiology may be multifactorial, but sun exposure appears to play a critical role. When detected early, the prognosis is excellent. Thus appropriate diagnosis, treatment, and surveillance are of utmost importance. Methods. From January 1994 to May 2012, 518 basal cell carcinomas were excised in our clinic. Data were collected retrospectively. Results. During 18-year period, 518 BCCs were excised from 486 patients. Most of the patients were males with a median age of 65.6 years. Most of the basal cell carcinomas were located in the head region. Nodular histological subtype dominated our series. Six percent of the excised lesions required reexcision because of involved margins. Our recurrence rate was 6.94% with the nose and the periauricular and periocular regions being the most common sites of occurrence. Conclusion. Although there is relatively low attributable mortality, the morbidity and cost of treatment are significant. A large body of information serves as a foundation for oncologic principles, diagnosis methods, surgical excisions, follow-up protocols, and reconstructive methodologies that are currently in use. Surgical ablation remains the mainstay of treatment.

No MeSH data available.


Related in: MedlinePlus

Recurrent BCC in the nose.
© Copyright Policy - open-access
Related In: Results  -  Collection


getmorefigures.php?uid=PMC3539390&req=5

fig9: Recurrent BCC in the nose.

Mentions: Although the results of primary excision are excellent, recurrences can occur. Recurrence rates are higher in the inner canthus, base of the nostril and preauricular, and postauricular areas [17]. This can be attributed to the scarcity of tissue, proximity to vital structures, and cosmetic considerations that must be taken into account in treating lesions on these locations. Recurrence rates are also increasing with increasing lesion size. We observed recurrence in 16 cases (3.08%). All occurred during the first four years. 8 were in the nose (Figure 9), 4 were in the periauricular area, and 4 were in the periorbital area.


Basal cell carcinoma: a single-center experience.

Abbas OL, Borman H - ISRN Dermatol (2012)

Recurrent BCC in the nose.
© Copyright Policy - open-access
Related In: Results  -  Collection

Show All Figures
getmorefigures.php?uid=PMC3539390&req=5

fig9: Recurrent BCC in the nose.
Mentions: Although the results of primary excision are excellent, recurrences can occur. Recurrence rates are higher in the inner canthus, base of the nostril and preauricular, and postauricular areas [17]. This can be attributed to the scarcity of tissue, proximity to vital structures, and cosmetic considerations that must be taken into account in treating lesions on these locations. Recurrence rates are also increasing with increasing lesion size. We observed recurrence in 16 cases (3.08%). All occurred during the first four years. 8 were in the nose (Figure 9), 4 were in the periauricular area, and 4 were in the periorbital area.

Bottom Line: Although there is relatively low attributable mortality, the morbidity and cost of treatment are significant.A large body of information serves as a foundation for oncologic principles, diagnosis methods, surgical excisions, follow-up protocols, and reconstructive methodologies that are currently in use.Surgical ablation remains the mainstay of treatment.

View Article: PubMed Central - PubMed

Affiliation: Department of Plastic, Reconstructive and Aesthetic Surgery, Baskent University Faculty of Medicine, 40000 Ankara, Turkey.

ABSTRACT
Background. Basal cell carcinoma comprises the vast majority of skin cancers. It predominantly affects fair-skinned individuals, and its incidence is rising rapidly. Etiology may be multifactorial, but sun exposure appears to play a critical role. When detected early, the prognosis is excellent. Thus appropriate diagnosis, treatment, and surveillance are of utmost importance. Methods. From January 1994 to May 2012, 518 basal cell carcinomas were excised in our clinic. Data were collected retrospectively. Results. During 18-year period, 518 BCCs were excised from 486 patients. Most of the patients were males with a median age of 65.6 years. Most of the basal cell carcinomas were located in the head region. Nodular histological subtype dominated our series. Six percent of the excised lesions required reexcision because of involved margins. Our recurrence rate was 6.94% with the nose and the periauricular and periocular regions being the most common sites of occurrence. Conclusion. Although there is relatively low attributable mortality, the morbidity and cost of treatment are significant. A large body of information serves as a foundation for oncologic principles, diagnosis methods, surgical excisions, follow-up protocols, and reconstructive methodologies that are currently in use. Surgical ablation remains the mainstay of treatment.

No MeSH data available.


Related in: MedlinePlus